Recurrence of atrial fibrillation after switching from brand to generic atenolol

Beta blockers are the initial treatment for rate control of supraventricular tachyarrhythmia in patients without a history of myocardial infarction or left ventricular dysfunction. In this article we report the recurrence of atrial fibrillation after switching to the generic formulation of atenolol.

Detalles Bibliográficos
Autores principales: Gallelli, Luca, Maida, Francesca, Staltari, Orietta, Rende, Pierandrea, Russo, Emilio, Caroleo, Benedetto, De Sarro, Giovambattista
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4319249/
https://www.ncbi.nlm.nih.gov/pubmed/25709353
http://dx.doi.org/10.4103/0976-500X.149146
_version_ 1782355930560593920
author Gallelli, Luca
Maida, Francesca
Staltari, Orietta
Rende, Pierandrea
Russo, Emilio
Caroleo, Benedetto
De Sarro, Giovambattista
author_facet Gallelli, Luca
Maida, Francesca
Staltari, Orietta
Rende, Pierandrea
Russo, Emilio
Caroleo, Benedetto
De Sarro, Giovambattista
author_sort Gallelli, Luca
collection PubMed
description Beta blockers are the initial treatment for rate control of supraventricular tachyarrhythmia in patients without a history of myocardial infarction or left ventricular dysfunction. In this article we report the recurrence of atrial fibrillation after switching to the generic formulation of atenolol.
format Online
Article
Text
id pubmed-4319249
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-43192492015-02-23 Recurrence of atrial fibrillation after switching from brand to generic atenolol Gallelli, Luca Maida, Francesca Staltari, Orietta Rende, Pierandrea Russo, Emilio Caroleo, Benedetto De Sarro, Giovambattista J Pharmacol Pharmacother Case Report Beta blockers are the initial treatment for rate control of supraventricular tachyarrhythmia in patients without a history of myocardial infarction or left ventricular dysfunction. In this article we report the recurrence of atrial fibrillation after switching to the generic formulation of atenolol. Medknow Publications & Media Pvt Ltd 2015 /pmc/articles/PMC4319249/ /pubmed/25709353 http://dx.doi.org/10.4103/0976-500X.149146 Text en Copyright: © Journal of Pharmacology and Pharmacotherapeutics http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Gallelli, Luca
Maida, Francesca
Staltari, Orietta
Rende, Pierandrea
Russo, Emilio
Caroleo, Benedetto
De Sarro, Giovambattista
Recurrence of atrial fibrillation after switching from brand to generic atenolol
title Recurrence of atrial fibrillation after switching from brand to generic atenolol
title_full Recurrence of atrial fibrillation after switching from brand to generic atenolol
title_fullStr Recurrence of atrial fibrillation after switching from brand to generic atenolol
title_full_unstemmed Recurrence of atrial fibrillation after switching from brand to generic atenolol
title_short Recurrence of atrial fibrillation after switching from brand to generic atenolol
title_sort recurrence of atrial fibrillation after switching from brand to generic atenolol
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4319249/
https://www.ncbi.nlm.nih.gov/pubmed/25709353
http://dx.doi.org/10.4103/0976-500X.149146
work_keys_str_mv AT gallelliluca recurrenceofatrialfibrillationafterswitchingfrombrandtogenericatenolol
AT maidafrancesca recurrenceofatrialfibrillationafterswitchingfrombrandtogenericatenolol
AT staltariorietta recurrenceofatrialfibrillationafterswitchingfrombrandtogenericatenolol
AT rendepierandrea recurrenceofatrialfibrillationafterswitchingfrombrandtogenericatenolol
AT russoemilio recurrenceofatrialfibrillationafterswitchingfrombrandtogenericatenolol
AT caroleobenedetto recurrenceofatrialfibrillationafterswitchingfrombrandtogenericatenolol
AT desarrogiovambattista recurrenceofatrialfibrillationafterswitchingfrombrandtogenericatenolol

Ejemplares similares